ArticleInvestigational new drugs2024

Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance.

Wenjie Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.